![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 32, 22693-22698, August 6, 1999
From the Department of Biomolecular Chemistry, University of
Wisconsin Medical School, Madison, Wisconsin 53706
The pathway by which segments of a polytopic
membrane protein are inserted into the membrane has not been resolved
in vivo. We have developed an in vivo kinetic
assay to examine the insertion pathway of the polytopic protein
bacterioopsin, the apoprotein of Halobacterium salinarum
bacteriorhodopsin. Strains were constructed that express the
bacteriorhodopsin mutants I4C:H6 and T5C:H6, which carry a unique Cys in the N-terminal extracellular domain and a
polyhistidine tag at the C terminus. Translocation of the N-terminal
domain was detected using a membrane-impermeant gel shift reagent to
derivatize the Cys residue of nascent radiolabeled molecules.
Derivatization was assessed by gel electrophoresis of the fully
elongated radiolabeled population. The time required to translocate and
fully derivatize the Cys residues of I4C:H6 and
T5C:H6 is 46 ± 9 and 61 ± 6 s,
respectively. This is significantly shorter than the elongation times
of the proteins, which are 114 ± 26 and 169 ± 16 s,
respectively. These results establish that translocation of the
bacterioopsin N terminus and insertion of the first transmembrane
segment occur co-translationally and confirm the use of the assay to
monitor the kinetics of polytopic membrane protein insertion in
vivo.
An essential step in the biogenesis of polytopic or multi-spanning
membrane proteins is the insertion of polypeptide segments into the
membrane. To elucidate the insertion mechanism in vivo, the
cellular factors that participate in this process must be characterized, and the pathway or sequence with which the polypeptide segments are inserted must be determined.
Cellular factors have been identified that mediate protein insertion
into the eukaryotic endoplasmic reticulum (1, 2) and bacterial
cytoplasmic membranes (3-5). These include the signal recognition
particle (SRP),1 a cytosolic
ribonucleoprotein complex, and the secretory translocase, a membrane
protein complex. SRP directs ribosome-bound nascent polypeptides to the
secretory translocase, which in eukaryotes forms an aqueous channel
into which the polypeptides are inserted (6, 7). Sequence conservation
of SRP and secretory translocase subunits (8, 9) suggests that aspects
of the insertion mechanism are universal.
Less is known about the insertion pathway of polytopic membrane
proteins. In eukaryotes, a co-translational, sequential insertion pathway (10, 11) is favored (12). In support of this model, the
insertion of transmembrane segments of polytopic membrane proteins has
been shown to be mechanistically coupled to translation (13-15) and to
occur sequentially (15-17). However, other evidence contradicts this
model. At least one eukaryotic polytopic membrane protein appears to
insert post-translationally (18), and several others exhibit multiple
topologies that may reflect a nonsequential insertion pathway (19-21).
In bacteria, it is not known whether insertion is co-translational and
sequential or more closely resembles protein secretion, where
translocation is independent from elongation (22, 23). There is
evidence for both post-translational (24) and co-translational (4, 5,
25) insertion mechanisms, but the issue remains controversial.
Studies of the insertion pathway have been problematic for several
reasons. First, methods used to monitor the membrane insertion of
protein segments are not time-resolved. Significant time elapses between polypeptide translation and analysis of insertion by methods such as cross-linking (14, 26) or proteolysis (16). During this time,
polypeptides may rearrange to yield a topology that does not reflect
the state of the polypeptides during insertion. Second, the topology of
most polytopic proteins is poorly defined, making it difficult to
interpret insertion studies unambiguously. Third, topological reporters
commonly used to study insertion, such as fusion domains (27, 28) or
glycosylation sequences (21), may alter protein topology or insertion.
Finally, the insertion pathway determined in vitro may
differ from the in vivo pathway because of differences in
the concentrations of SRP or secretory translocase subunits, the
membrane potential, or ionic conditions.
To examine the insertion pathway of a polytopic membrane protein
in vivo, we have studied bacteriorhodopsin (BR), a
light-driven proton pump of known structure (29) expressed in the sole
membrane of the archaeon Halobacterium salinarum. BR
contains a 248-amino acid polypeptide, bacterioopsin (BO), which forms
seven transmembrane In this work, we have developed an in vivo assay of BO
insertion and used it to characterize the translocation kinetics of the
first extracellular domain of the protein. The assay monitors the
translocation of engineered Cys residues in BO with a
membrane-impermeant gel shift reagent specific for sulfhydryl groups.
Comparison of the translocation time of Cys residues near the N
terminus and the BO elongation time indicated that the N-terminal
domain inserts co-translationally. These results establish the assay as
a direct method to monitor the insertion of transmembrane segments
in vivo and raise the possibility that the predominant
pathway of polytopic membrane protein insertion is co-translational in
all taxonomic domains.
Materials--
Oligonucleotides were obtained from Life
Technologies Inc., Taq polymerase and ligase from Promega
(Madison, WI), and restriction endonucleases from New England Biolabs
(Beverly, MA). Ni2+-nitrilotriacetic acid Superflow was
obtained from Qiagen (Valencia, CA). Redivue [35S]Met
(>1,000 Ci/mmol) was obtained from Amersham Pharmacia Biotech, and
4-acetamido-4'maleimidylstilbene-2-2'-disulfonic acid disodium salt
(AMS) was from Molecular Probes (Eugene, OR).
Plasmid and Strain Construction--
Mutations in bop
were constructed in Escherichia coli by polymerase chain
reaction. To introduce a sequence encoding six His residues at the BO C
terminus, the primers TGTTGAGCGACGCTGGAAAG and
GGCGACGGCGCGGCCGCGCACCACCACCACCACCACTGATCGCACACGCAG were
used (codon changes are underlined). The last three codons of
bop were removed by these changes. Constructs encoding Cys
at amino acids 4 and 5 of mature BO were created with the primers
GCGCGGATCCGACGTGAAGA and CCGGACGTCCGGTGCACTGGGCCTGCGATA or
CCGGACGTCCGCAGATCTGGGCCTGCGATA. Restriction fragments
derived from the polymerase chain reaction products were cloned in
pMPK62 (31) to yield bop genes encoding His-tagged BO with a
single Cys near the N terminus. Recombinant H. salinarum
strains expressing the BR variants were created by targeted gene
replacement (31). The bop sequence of the recombinant strains was confirmed by fluorescent dye terminator cycle sequencing (ABI Prism, Foster City, CA).
Expression and Characterization of Mutant BR--
To induce BR
synthesis, H. salinarum was cultured with illumination (32)
in 120 ml of peptone medium for 2 days (33). Cell lysates were
prepared, and BR levels were determined as described (34) from the
change in absorbance at 585 nm between light- and dark-adapted samples.
BR levels were expressed as percentages of total cell protein
determined by the BCA assay (Pierce). For spectral analysis, mutant
proteins were purified (33) and scanned in 30 mM sodium
phosphate, 0.025% sodium azide, pH 6.9, with a Perkin-Elmer Purification of His-tagged BO--
Full-length His-tagged BO was
purified from H. salinarum to >90% homogeneity by
denaturing Ni2+ affinity chromatography at room
temperature. Cultures (120 ml) were harvested at 8,000 × g for 10 min at room temperature, and the pellet was
resuspended in 1.2 ml of medium salts (33). A 25-µl aliquot was mixed
with 1.0 ml of 60 units DNaseI/ml and 100 µg phenylmethylsulfonyl
fluoride/ml (lysis solution) and incubated for ~10 min. Samples were
combined with 40 µl of Ni2+-nitrilotriacetic acid beads
and adjusted with buffer to a final concentration of 300 mM
NaCl, 50 mM Tris-Cl, pH 7.0, 0.1% SDS in 1.4 ml. After
incubation for 2 h, beads were sedimented and washed with 1 ml of
0.01% SDS, 300 mM NaCl, 50 mM Tris-Cl, pH 7.0, 5 mM imidazole. Bound protein was eluted by incubating for 0.5 h with 50 mM imidazole, 20 mM EDTA, 50 mM dithiothreitol (DTT), in Laemmli sample buffer (35).
His-tagged proteins were recovered quantitatively, as determined by
immunoblotting with BR-114 antibody provided by Dr. H. G. Khorana
(data not shown).
Measurement of Elongation Time--
To establish the elongation
time of His-tagged BO, cells were radiolabeled as described (36) with
the following modifications. Cells cultured to induce BR were
harvested, washed, resuspended in medium salts containing 0.5%
L-Ala and shaken at 40 °C for 2.5 h with
illumination (36). Cells were then harvested and resuspended in
The elongation rate was determined by fitting the elongation time
course data with a step-wise function similar to that described (37).
The maximum extent of radiolabeling was estimated by averaging points
in the plateau region. The data were fit with a function containing
nine steps distributed according to the spacing of Met residues in BO,
with an increase in radiolabeling of Measurement of the Met Equilibration Time--
To determine the
lag in radiolabeling due to uptake and equilibration of Met during the
pulse and chase, cells were radiolabeled or pulse-chase radiolabeled
with [35S]Met as above. At various times, aliquots were
removed and added to 40 volumes of lysis solution. Total protein in 10 µl was precipitated onto filter paper with trichloroacetic acid (10%
w/v). [35S]Met incorporation was quantified by
PhosphorImager analysis, plotted as a function of time after the pulse
and fit by linear regression. The lag in [35S]Met
incorporation after the pulse is given by the x intercept of
the fit to data from radiolabeled cells. The lag in incorporation of
nonradioactive Met after the chase is given by the time between chase
addition and the intersection of the curves fit to data from
radiolabeled and pulse-chase radiolabeled cells.
Measurement of Elongation Time by Lag in Radiolabel
Incorporation--
Elongation times were also determined by a method
in which the lag times preceding steady-state radiolabeling of total
cell protein and a specific protein are compared (38). Cells were radiolabeled and lysed at various times after the pulse. The time course of [35S]Met incorporation into total cell protein
and His-tagged BO was determined as in previous sections. Linear fits
of the data yielded x intercepts that correspond to the lags
preceding steady-state radiolabeling of total cell protein and
His-tagged BO, respectively. The difference in the x
intercepts equals 1/2 the elongation time of His-tagged BO.
Measurement of the Translocation Time--
To measure
translocation times, cells expressing mutant BR were pulse-chase
radiolabeled as above, except 2 µl of 200 mM AMS in
dimethyl sulfoxide were added to 400 µl of the cells 1 min before
radiolabeling. At various times after the pulse, 50 µl of the cells
were combined with 50 µl of 20 mM DTT, incubated for 10 min at 37 °C to complete elongation of the radiolabeled protein, and
mixed with 1.0 ml of lysis solution. His-tagged protein was recovered
and electrophoresed as above, except that a pH 7.5 separating gel was
used, and gels were run for 21 h at 11 °C at 200 V on a 20-cm
gel apparatus to maximize resolution. The derivatized protein was
expressed as a percentage of the total radioactivity in each lane and
plotted as a function of time. These data were fit to the curve
generated from fitting the elongation data, with a shift along the time
axis as the only adjustable parameter. The magnitude of this shift is
equal to the difference in the translocation and elongation times. The
length of the polypeptide upon translocation of the Cys residue was
estimated by subtracting the value of this shift from the elongation
time and multiplying this difference by the elongation rate.
Experimental Rationale--
The in vivo kinetic
assay is designed to detect when a transmembrane segment inserts into
the membrane relative to other events in the lifetime of a membrane
protein. In the assay, insertion is monitored by the translocation of a
unique extracellular Cys across the cytoplasmic membrane. Translocation
is detected by derivatizing Cys with AMS, a membrane-impermeant
sulfhydryl reagent that shifts protein mobility on SDS-polyacrylamide
gel electrophoresis (39, 40). Cells expressing the membrane protein are
preincubated in AMS and then radiolabeled to monitor nascent
polypeptides (Fig. 1, I). At
various times after radiolabeling, derivatization is quenched with a
thiol reagent, DTT (Fig. 1, II). Samples are then incubated
to complete elongation of the radiolabeled population, and the
full-length protein is purified (Fig. 1, III). Derivatized and underivatized protein are separated by SDS-polyacrylamide gel
electrophoresis and quantified. By this approach, the fraction of the
radiolabeled population in which Cys has been translocated may be
determined as a function of time after translation is initiated. To
assess whether insertion occurs co- or post-translationally, the
translocation time course is compared with the elongation time course,
measured independently by pulse-chase radiolabeling.
Expression and Characterization of Mutant Proteins--
To develop
the assay, Cys was substituted for Ile4 or
Thr5, located in the 8-amino acid extracellular domain at
the N terminus of mature BO (41). Translocation of this domain reports
on the insertion of the adjacent transmembrane Reactivity of the Mutant Proteins--
To demonstrate the
reactivity of the Cys residues, the mutant proteins were derivatized
with AMS. A shift was observed with T5C:H6 (Fig.
2A) and I4C:H6
(data not shown) but not BO:H6, which lacks Cys (Fig.
2A). The reaction of AMS with T5C:H6 in intact cells was complete in ~10 s and was effectively quenched by DTT (Fig.
2B). Thus, AMS is sulfhydryl-specific and reacts
rapidly.
Translocation Time of the BO N Terminus--
As the first step in
establishing the translocation time of the N-terminal domain, AMS
derivatization of T5C:H6 and I4C:H6 was
measured at various times after radiolabeling according to the scheme
in Fig. 1. Results are shown for T5C:H6 (Fig.
3); similar results were obtained for
I4C:H6 (data not shown). A substantial fraction of
radiolabeled T5C:H6 was derivatized at the earliest time
point, indicating that many of the nascent polypeptides are inserted at
the start of the assay (Fig. 3A). Derivatization increased to a plateau of
Several observations suggest that the appearance of derivatized protein
at early times is not due to derivatization of nascent BO inside the
cell. First, AMS is unlikely to cross the membrane because of its two
negatively charged sulfonate groups. It has been used in other systems
as a membrane impermeant reagent (42-44). Second, translocation time
courses similar to that in Fig. 3B were obtained when the
preincubation with AMS was extended by several minutes or when the
reagent was added after pulse-chase radiolabeling (data not
shown). Finally, different translocation time courses are observed with
Cys located in other extracellular regions of the protein, arguing that
AMS derivatization reflects Cys
translocation.2
Measurement of Elongation Time--
To determine whether
translocation of Cys residues near the N terminus occurs co- or
post-translationally, we measured the BO elongation time by labeling
cells with a short pulse of [35S]Met followed by a
nonradioactive Met chase. The point at which incorporation of
[35S]Met into full-length BO reaches a plateau, corrected
for the lag in Met equilibration, reflects the elongation time of the protein. [35S]Met incorporation into T5C:H6
is shown in Fig. 4A; similar
results were obtained with I4C:H6 and BO:H6
(data not shown). A plot of the data, normalized for the total number
of Met residues in the protein (Fig. 4B, open
circles), was fit with a curve that accounts for the distribution
of Met in BO (Fig. 4B, dashed line). Prior to
fitting, the data were corrected for lags due to pulse and chase
equilibration, which require 19 ± 3 and 22 ± 2 s,
respectively (Fig. 4C). From the curve, the average
elongation rates and corresponding elongation times for
I4C:H6 and T5C:H6 were found to be within ~30% of BO:H6 (Table II).
Although the source of this variation has not been identified, the
effect on the calculation of translocated chain length is minimal (see
below). The elongation values for I4C:H6 and
T5C:H6 are in excellent agreement with those obtained by an
independent method (Table II, column 3), indicating that the difference
in rates and the corrections made for Met equilibration are valid.
The BO elongation rates (Table II) are lower than measured rates in
eukaryotes (3-6 amino acids/s (45)) and bacteria (12-20 amino acids/s
(46)). To determine whether the BO elongation rate was atypical, the
elongation rates of several prominent radiolabeled proteins in cell
lysates (Mr = ~24-57 kDa) were measured by
the pulse-chase radiolabeling method used for BO. Elongation rates from
1.3 to 5.5 amino acids/s were obtained (data not shown), indicating
that translation is relatively slow in H. salinarum and that
BO translation is not unusual.
Comparison of the Translocation and Elongation
Times--
Translocation and elongation data were compared to
determine when the T5C:H6 N-terminal domain translocates
relative to synthesis of the full-length protein (Fig. 4B,
closed circles). Strikingly, Cys translocation occurs
significantly before elongation; similar results were obtained for
I4C:H6. Thus, translocation of the N-terminal extracellular
domain and insertion of the first transmembrane
The translocation and elongation data were used to estimate the length
of the polypeptide upon translocation of the Cys residue. Because both
data sets reflect BO maturation, they were fit by similar curves,
except that the fit of the translocation data was displaced along the
time axis. The fits of the translocation and elongation data for
T5C:H6 are shown in Fig. 4B; similar analysis was applied to I4C:H6. By this analysis, translocation of
the Cys residue in T5C:H6 occurs more than 70 s before
elongation is complete (Table II, columns 1 and 2). Multiplying the
time required for translocation by the average elongation rate (Table II), the length of the T5C:H6 polypeptide upon
translocation of the Cys residue was calculated to be 92 ± 12 amino acids, assuming that the polypeptide is translated at a uniform
rate. A similar result was obtained for I4C:H6 (Table II).
Notably, even though the elongation rates differ, the calculated
translocated chain length agrees. Correcting for the ~10 s required
for complete derivatization (Fig. 2B), the calculated chain
length upon translocation of the Cys residue in T5C:H6 is
77 ± 12 amino acids.
We have developed a kinetic assay to monitor the membrane
insertion of polytopic proteins and used it to demonstrate that the
first transmembrane segment of BO inserts into the H. salinarum membrane co-translationally. To our knowledge, the
insertion kinetics of a polytopic membrane protein have not been
established in vivo in any other organism. The assay was
feasible because the H. salinarum membrane is accessible to
the external environment, AMS reacts with translocated Cys very
rapidly, and BO translation is sufficiently slow to resolve
translocation events. Although H. salinarum is ideal for
this approach, it may be possible to apply the method to other
prokaryotes in which the cytoplasmic membrane is accessible and
translation is slow. Examination of other Cys substitutions in BO with
this assay will be invaluable for determining the complete insertion
pathway of this protein.
Our results suggest that the insertion pathway of an archaeal polytopic
membrane protein is similar to the co-translational pathway proposed
for eukaryotic polytopic proteins (10, 11). In this pathway,
ribosome-bound nascent polypeptides must reach a length of ~70 amino
acids to traverse the membrane (47, 48). A similar length of 77 ± 12 amino acids is synthesized in T5C:H6 before the Cys
residue is translocated, suggesting that ribosomes synthesizing BO are
in close proximity to the membrane. The similarity between the membrane
insertion of archaeal and eukaryotic proteins may reflect the
conservation of "information pathways" such as transcription and
translation in archaea and eukaryotes (49). These results, together
with evidence of co-translational insertion in bacteria (4, 5, 25),
raise the possibility that the predominant mode of polytopic membrane
protein insertion is co-translational in all three taxonomic domains.
The finding that translocation of the BO N terminus is coupled to
translation has important implications for understanding BR folding.
Because the N-terminal transmembrane segment is the first region of the
mature protein to achieve a transmembrane configuration, it may
interact with other regions of BO to promote their folding within the
membrane. Recent evidence that the first two helices of BO facilitate
the folding of the remaining helices supports this idea (50).
Co-translational insertion of the first transmembrane segment may
nucleate folding of the remaining transmembrane segments and must be
considered in studies of BO folding in vitro.
Co-translational translocation of the BO N terminus is consistent with
both a translocase-dependent mechanism, in which protein factors within the lipid bilayer mediate insertion (10, 11), and a
spontaneous mechanism, in which no such factors are involved (51, 52).
Although our results do not distinguish between these possibilities, we
propose that BO insertion is mediated by SRP and the secretory
translocase, as has been demonstrated for eukaryotic and bacterial
membrane proteins. This is reasonable, given that H. salinarum SRP is implicated in BO biogenesis (53) and that
homologs of secretory translocase subunits exist in several archaea
(9), including H. salinarum.3 Direct
studies are required to test whether these cellular factors mediate BO insertion.
We thank T. A. Isenbarger for
the N-terminal Cys mutant proteins, J. M. Janz for technical
support, and R. H. Fillingame, T. Silhavy, and members of the
Krebs laboratory for comments on the manuscript.
*
This work was supported by National Science Foundation Grant
MCB-9514280 and in part by a grant to the University of Wisconsin Medical School under the Howard Hughes Medical Institute Research Resources Program for Medical Schools.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
2
H. Dale and M. Krebs, unpublished results.
3
C. M. Angevine and M. P. Krebs,
unpublished results.
The abbreviations used are:
SRP, signal
recognition particle;
AMS, 4-acetamido-4'maleimidylstilbene-2-2'-disulfonic acid disodium salt;
BO, bacterioopsin;
BR, bacteriorhodopsin;
DTT, dithiothreitol.
Membrane Insertion Kinetics of a Protein Domain In
Vivo
THE BACTERIOOPSIN N TERMINUS INSERTS CO-TRANSLATIONALLY*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-helices that surround a covalently bound
retinal cofactor. The polypeptide is initially synthesized with a
13-amino acid presequence that is cleaved during biogenesis (30).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
2 spectrophotometer.
th volume medium salts containing 0.5% L-Ala.
A 400-µl concentrated cell suspension was stirred at 37 °C in a
glass vial exposed to >520 nm illumination. After 5 min, 160 µCi of
[35S]Met was added (pulse) followed 20 s later by
400 µl of 10 mM nonradioactive Met in medium salts
containing 0.5% L-Ala (chase). At various times, 50 µl
of radiolabeled cells were combined with 1.0 ml of lysis solution to
halt synthesis. Full-length His-tagged BO was recovered by
Ni2+ affinity chromatography and electrophoresed on a 14%
polyacrylamide gel (35), which was stained with Coomassie and dried.
Radioactivity in BO was quantified with a PhosphorImager (Molecular
Dynamics, Sunnyvale, CA) and normalized by the intensity of the
Coomassie-stained bands.
th the plateau value at
each step. A constant elongation rate was assumed and was the only
adjustable parameter. To correct for lags due to Met equilibration, the
function was fit starting at 41 s (see below and "Results").
The elongation time was calculated by dividing the length of mature
His-tagged BO, 251 amino acids, by the derived elongation rate. The
13-amino acid presequence is not observed by this approach, presumably
due to its rapid cleavage during biogenesis. Consequently,
radiolabeling of this region is not detected and is not included in the analysis.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (9K):
[in a new window]
Fig. 1.
Assay scheme. Top panel,
timeline of the assay. Cells expressing a membrane protein containing a
unique extracellular Cys are preincubated with AMS and pulse-chase
radiolabeled with [35S]Met. At various times after the
pulse, AMS is quenched with DTT. Cells are incubated further to
completely elongate the radiolabeled proteins before purification.
Bottom panel, assay of a membrane protein containing an
extracellular Cys near the N terminus. The nascent population is shown
immediately after the pulse (I), after the AMS reaction is
quenched (II), and after the radiolabeled population is
elongated (III). Met residues are assumed to be evenly
spaced. *, incorporation of [35S]Met; C, Cys;
circled C, AMS-derivatized Cys.
-helix of mature BO, which includes residues 9-31. A hexahistidine tag was introduced at
the C terminus of the wild-type and Cys mutant proteins for purification. The His-tagged Cys mutant proteins, I4C:H6
and T5C:H6, were expressed in H. salinarum at
significantly lower levels than wild-type BR but only slightly lower
than BR:H6 (Table I). The proteins could be purified in a form similar to the wild-type purple
membrane (33) and had normal spectral properties (Table I), indicating
that they assemble normally and bind the retinal chromaphore.
Expression levels and spectral characteristics of wild-type and mutant
BR

View larger version (27K):
[in a new window]
Fig. 2.
AMS derivatization of mutant BR in H. salinarum. A, demonstration of a gel shift.
BO:H6 or T5C:H6 cells were incubated in 5 mM tris(2-carboxyethyl)phosphine in medium salts for 3 h and treated with (+) or without (
) 6.25 mM AMS for 30 min at 37 °C. Proteins were then purified by Ni2+
affinity chromatography, electrophoresed and stained with Coomassie.
B, rate of AMS derivatization. T5C:H6 cells were
radiolabeled with [35S]Met for 20 s, chased with
nonradioactive Met, incubated for 3 min to complete T5C:H6
elongation, and combined with AMS (final concentration, 0.25 mM). Aliquots were removed at various times and quenched
with an equal volume of 20 mM DTT in medium salts.
Full-length T5C:H6 was purified by Ni2+
affinity chromatography and electrophoresed. The percentage of
derivatized, radiolabeled T5C:H6 was determined by
PhosphorImager analysis. A monoexponetial fit of the data yielded a
time of ~10 s for 99% completion.
90% (Fig. 3B), consistent with maturation
of the nascent radiolabeled population.

View larger version (31K):
[in a new window]
Fig. 3.
Translocation time course of
T5C:H6. A, PhosphorImager analysis of a
translocation time course. Cells expressing T5C:H6 were
incubated in AMS and radiolabeled as described for Fig. 2B.
At 30-s intervals (except for the first two points) aliquots were
removed and quenched with DTT as in Fig. 2B. Following a
10-min incubation, samples were treated and analyzed as in Fig.
2B. d, derivatized; u, underivatized.
B, the percentage of derivatized protein was plotted as a
function of the time between [35S]Met and DTT
addition.

View larger version (22K):
[in a new window]
Fig. 4.
Comparison of T5C:H6 elongation
and translocation. A, PhosphorImager analysis of an
elongation time course of cells expressing T5C:H6. Cells
expressing T5C:H6 were radiolabeled as in Fig.
2B. Aliquots were removed at the times shown in Fig.
3A and lysed. The full-length protein was purified by
Ni2+ affinity chromatography and electrophoresed.
B, elongation and translocation time courses.
[35S]Met incorporation in the samples shown in Fig.
4A was quantified by PhosphorImager analysis, plotted as a
function of time (open circles) and fit to a curve that
reflects the distribution of the nine Met residues in BO (dashed
line). For comparison, the translocation time course shown in Fig.
3B was adjusted so that plateau values correspond to 100%
translocation (closed circles) and fit with a similar curve
(solid line). C, measurement of the Met
equilibration time. Cells expressing T5C:H6 were pulsed
with [35S]Met (closed circles) or pulsed for 1 min and chased (open circles) at the time indicated
(arrow). At various times, aliquots were removed and
precipitated with trichloroacetic acid (10% w/v). Radioactivity in
trichloroacetic acid-precipitable total protein was measured at each
time point in duplicate and fit by linear regression. The time required
for equilibration of the pulse and chase was calculated as described
under "Experimental Procedures."
Translocation and elongation times of mutant BR
-helix of BO occur
co-translationally in H. salinarum.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
To whom correspondence should be addressed.; Tel.: 608-265-5491;
Fax: 608-262-5253; mpkrebs@facstaff.wisc.edu.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Rapoport, T. A.,
Jungnickel, B.,
and Kutay, U.
(1996)
Annu. Rev. Biochem.
65,
271-303[CrossRef][Medline]
[Order article via Infotrieve]
2.
Johnson, A. E.
(1997)
Trends Cell Biol.
7,
90-95
[Medline]
[Order article via Infotrieve] 3.
Ulbrandt, N. D.,
Newitt, J. A.,
and Bernstein, H. D.
(1997)
Cell
88,
187-196[CrossRef][Medline]
[Order article via Infotrieve]
4.
Newitt, J. A.,
and Bernstein, H. D.
(1998)
J. Biol. Chem.
273,
12451-12456 5.
Valent, Q. A.,
Scotti, P. A.,
High, S.,
de Gier, J. W.,
von Heijne, G.,
Lentzen, G.,
Wintermeyer, W.,
Oudega, B.,
and Luirink, J.
(1998)
EMBO J.
17,
2504-2512[CrossRef][Medline]
[Order article via Infotrieve]
6.
Simon, S. M.,
and Blobel, G.
(1991)
Cell
65,
371-380[CrossRef][Medline]
[Order article via Infotrieve]
7.
Hanein, D.,
Matlack, K. E. S.,
Jungnickel, B.,
Plath, K.,
Kalies, K. U.,
Miller, K. R.,
Rapoport, T. A.,
and Akey, C. W.
(1996)
Cell
87,
721-732[CrossRef][Medline]
[Order article via Infotrieve]
8.
Hartmann, E.,
Sommer, T.,
Prehn, S.,
Gorlich, D.,
Jentsch, S.,
and Rapoport, T. A.
(1994)
Nature
367,
654-657[CrossRef][Medline]
[Order article via Infotrieve]
9.
Pohlschroder, M.,
Prinz, W. A.,
Hartmann, E.,
and Beckwith, J.
(1997)
Cell
91,
563-566[CrossRef][Medline]
[Order article via Infotrieve]
10.
Blobel, G.
(1980)
Proc. Natl. Acad. Sci. U. S. A.
77,
1496-1500 11.
Singer, S. J.,
Maher, P. A.,
and Yaffe, M. P.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
1960-1964 12.
Bibi, E.
(1998)
Trends Biochem. Sci.
23,
51-55[CrossRef][Medline]
[Order article via Infotrieve]
13.
Borel, A. C.,
and Simon, S. M.
(1996)
Cell
85,
379-389[CrossRef][Medline]
[Order article via Infotrieve]
14.
Do, H.,
Falcone, D.,
Lin, J.,
Andrews, D. W.,
and Johnson, A. E.
(1996)
Cell
85,
369-378[CrossRef][Medline]
[Order article via Infotrieve]
15.
Mothes, W.,
Heinrich, S. U.,
Graf, R.,
Nilsson, I.,
von Heijne, G.,
Brunner, J.,
and Rapoport, T. A.
(1997)
Cell
89,
523-533[CrossRef][Medline]
[Order article via Infotrieve]
16.
Wessels, H. P.,
and Spiess, M.
(1988)
Cell
55,
61-70[CrossRef][Medline]
[Order article via Infotrieve]
17.
Borel, A. C.,
and Simon, S. M.
(1996)
Biochemistry
35,
10587-10595[CrossRef][Medline]
[Order article via Infotrieve]
18.
Mueckler, M.,
and Lodish, H. F.
(1986)
Cell
44,
629-637[CrossRef][Medline]
[Order article via Infotrieve]
19.
Skach, W. R.,
and Lingappa, V. R.
(1993)
J. Biol. Chem.
268,
23552-23561 20.
Moss, K.,
Helm, A.,
Lu, Y.,
Bragin, A.,
and Skach, W. R.
(1998)
Mol. Biol. Cell
9,
2681-2697 21.
Ota, K.,
Sakaguchi, M.,
vonHeijne, G.,
Hamasaki, N.,
and Katsuyoshi, M.
(1998)
Mol. Cell
2,
495-503[CrossRef][Medline]
[Order article via Infotrieve]
22.
Randall, L. L.
(1983)
Cell
33,
231-240[CrossRef][Medline]
[Order article via Infotrieve]
23.
Wickner, W.,
and Leonard, M. R.
(1996)
J. Biol. Chem.
271,
29514-29516 24.
Bochkareva, E.,
Seluanov, A.,
Bibi, E.,
and Girshovich, A.
(1996)
J. Biol. Chem.
271,
22256-22261 25.
Macfarlane, J.,
and Muller, M.
(1995)
Eur. J. Biochem.
233,
766-771[Medline]
[Order article via Infotrieve]
26.
Martoglio, B.,
Hofmann, M. W.,
Brunner, J.,
and Dobberstein, B.
(1995)
Cell
81,
207-214[CrossRef][Medline]
[Order article via Infotrieve]
27.
Traxler, B.,
Lee, C.,
Boyd, D.,
and Beckwith, J.
(1992)
J. Biol. Chem.
267,
5339-5345 28.
Jander, G.,
Cronan, J. E., Jr.,
and Beckwith, J.
(1996)
J. Bacteriol.
178,
3049-3058 29.
Lanyi, J. K.
(1997)
J. Biol. Chem.
272,
31209-31212 30.
Seehra, J. S.,
and Khorana, H. G.
(1984)
J. Biol. Chem.
259,
4187-4193 31.
Krebs, M. P.,
Mollaaghababa, R.,
and Khorana, H. G.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
1987-1991 32.
Krebs, M. P.,
Li, W.,
and Halambeck, T. P.
(1997)
J. Mol. Biol.
267,
172-183[CrossRef][Medline]
[Order article via Infotrieve]
33.
Oesterhelt, D.,
and Stoeckenius, W.
(1974)
Methods Enzymol.
31,
667-678[Medline]
[Order article via Infotrieve]
34.
Krebs, M. P.,
Hauss, T.,
Heyn, M. P.,
RajBhandary, U. L.,
and Khorana, H. G.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
859-863 35.
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
36.
Sumper, M.,
and Herrmann, G.
(1978)
Eur. J. Biochem.
89,
229-235[Medline]
[Order article via Infotrieve]
37.
Sørensen, M. A.,
Kurland, C. G.,
and Pedersen, S.
(1989)
J. Mol. Biol.
207,
365-377[CrossRef][Medline]
[Order article via Infotrieve]
38.
Braakman, I.,
Hoover-Litty, H.,
Wagner, K. R.,
and Helenius, A.
(1991)
J. Cell Biol.
114,
401-411 39.
Uchida, K.,
Mori, H.,
and Mizushima, S.
(1995)
J. Biol. Chem.
270,
30862-30868 40.
Joly, J. C.,
and Swartz, J. R.
(1997)
Biochemistry
36,
10067-10072[CrossRef][Medline]
[Order article via Infotrieve]
41.
Grigorieff, N.,
Ceska, T. A.,
Downing, K. H.,
Baldwin, J. M.,
and Henderson, R.
(1996)
J. Mol. Biol.
259,
393-421[CrossRef][Medline]
[Order article via Infotrieve]
42.
Lutsenko, S.,
Daoud, S.,
and Kaplan, J. H.
(1997)
J. Biol. Chem.
272,
5249-5255 43.
Long, J. C.,
Wang, S.,
and Vik, S. B.
(1998)
J. Biol. Chem.
273,
16235-16240 44.
Spannagel, C.,
Vaillier, J.,
Chaignepain, S.,
and Velours, J.
(1998)
Biochemistry
37,
615-621[CrossRef][Medline]
[Order article via Infotrieve]
45.
Hershey, J. W.
(1991)
Annu. Rev. Biochem.
60,
717-755[CrossRef][Medline]
[Order article via Infotrieve]
46.
Bremer, H.,
and Dennis, P. P.
(1996)
in
Escherichia coli and Salmonella: Cellular and Molecular Biology
(Neidhardt, F. C.
, Curtiss, R.
, Ingraham, J. L.
, Lin, E. C. C.
, Low, K. B.
, Magasanik, B.
, Resnikoff, W. K.
, Riley, M.
, Schaechter, M.
, and Umbarger, H. E.., eds), Vol. 2
, pp. 1553-1569, ASM Press, Washington, D.C.
47.
Matlack, K. E.,
and Walter, P.
(1995)
J. Biol. Chem.
270,
6170-6180 48.
Crowley, K. S.,
Liao, S.,
Worrell, V. E.,
Reinhart, G. D.,
and Johnson, A. E.
(1994)
Cell
78,
461-471[CrossRef][Medline]
[Order article via Infotrieve]
49.
Brown, J. R.,
and Doolittle, W. F.
(1997)
Microbiol. Mol. Biol. Rev.
61,
456-502[Abstract]
50.
Lüneberg, J.,
Widmann, M.,
Dathe, M.,
and Marti, T.
(1998)
J. Biol. Chem.
273,
28822-28830 51.
Wickner, W. T.,
and Lodish, H. F.
(1985)
Science
230,
400-407 52.
von Heijne, G.
(1995)
Bioessays
17,
25-30[CrossRef][Medline]
[Order article via Infotrieve]
53.
Gropp, R.,
Gropp, F.,
and Betlach, M. C.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
1204-1208
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. Eichler and M. W. W. Adams Posttranslational Protein Modification in Archaea Microbiol. Mol. Biol. Rev., September 1, 2005; 69(3): 393 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ring and J. Eichler In the Archaea Haloferax volcanii, Membrane Protein Biogenesis and Protein Synthesis Rates Are Affected by Decreased Ribosomal Binding to the Translocon J. Biol. Chem., December 17, 2004; 279(51): 53160 - 53166. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Irihimovitch and J. Eichler Post-translational Secretion of Fusion Proteins in the Halophilic Archaea Haloferax volcanii J. Biol. Chem., April 4, 2003; 278(15): 12881 - 12887. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Rose and M. Pohlschroder In Vivo Analysis of an Essential Archaeal Signal Recognition Particle in Its Native Host J. Bacteriol., June 15, 2002; 184(12): 3260 - 3267. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Peck, E. A. Johnson, and M. P. Krebs Identification of a Lycopene {beta}-Cyclase Required for Bacteriorhodopsin Biogenesis in the Archaeon Halobacterium salinarum J. Bacteriol., June 1, 2002; 184(11): 2889 - 2897. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Dale, C. M. Angevine, and M. P. Krebs Ordered membrane insertion of an archaeal opsin in vivo PNAS, June 23, 2000; (2000) 140216497. [Abstract] [Full Text] |
||||
![]() |
R. F. Peck, C. Echavarri-Erasun, E. A. Johnson, W. V. Ng, S. P. Kennedy, L. Hood, S. DasSarma, and M. P. Krebs brp and blh Are Required for Synthesis of the Retinal Cofactor of Bacteriorhodopsin in Halobacterium salinarum J. Biol. Chem., February 16, 2001; 276(8): 5739 - 5744. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ortenberg and M. Mevarech Evidence for Post-translational Membrane Insertion of the Integral Membrane Protein Bacterioopsin Expressed in the Heterologous Halophilic Archaeon Haloferax volcanii J. Biol. Chem., July 21, 2000; 275(30): 22839 - 22846. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Dale, C. M. Angevine, and M. P. Krebs Ordered membrane insertion of an archaeal opsin in vivo PNAS, July 5, 2000; 97(14): 7847 - 7852. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||